Literature DB >> 15735659

Diffuse alveolar hemorrhage following gemtuzumab ozogamicin.

T S Lin, S L Penza, B R Avalos, M R Lucarelli, S S Farag, J C Byrd, E A Copelan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15735659     DOI： 10.1038/sj.bmt.1704886

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

Review 1.  What role does gemtuzumab ozogamicin have in the treatment of acute myelogenous leukemia?

Authors:  István Molnár; Bayard L Powell
Journal:  Curr Hematol Malig Rep       Date:  2007-05       Impact factor: 3.952

Review 2.  Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.

Authors:  Bobbak Vahid; Paul E Marik
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

Review 3.  Anticancer therapy and lung injury: molecular mechanisms.

Authors:  Li Li; Henry Mok; Pavan Jhaveri; Mark D Bonnen; Andrew G Sikora; N Tony Eissa; Ritsuko U Komaki; Yohannes T Ghebre
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-23       Impact factor: 4.512
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.